Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $0.3051 (-19.54%) ($0.3051 - $0.3051) on Tue. May. 3, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 10.67% (three month average) | RSI | 30 | Latest Price | $0.3051(-19.54%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | ANPC declines -13.8% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) XLK(93%) REMX(83%) IVE(82%) EWP(76%) QQQ(74%) | Factors Impacting ANPC price | ANPC will decline at least -5.335% in a week (0% probabilities). SHY(-47%) VCSH(-36%) BND(-36%) BNDX(-35%) VCIT(-21%) | | | | | Relative Volatility | | | | Market Trend Strength | -5.335% (StdDev 10.67%) | Hourly BBV | -0.7 () | Intraday Trend | 0% | | | |
|
Resistance Level | $0.4 | 5 Day Moving Average | $0.34(-10.26%) | 10 Day Moving Average | $0.34(-10.26%) | 20 Day Moving Average | $0.4(-23.73%) | To recent high | -66.6% | To recent low | 7.1% | Market Cap | $3m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |